Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
A 0.800 GeneticVariation GWASCAT Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. 17603485

2007

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
A 0.800 GeneticVariation GWASCAT Multiple loci identified in a genome-wide association study of prostate cancer. 18264096

2008

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
C 0.740 GeneticVariation GWASCAT Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Notably, rs4430796 was significantly associated with prostate cancer among men diagnosed at an early (<50 years) but not later age (P = 0.006 versus P = 0.118). 18701471

2008

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.740 GeneticVariation BEFREE SNPs rs4430796 and rs7501939, which were in strong linkage disequilibrium (r(2) = 0.68), showed the strongest evidence of prostate cancer association. 18701471

2008

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Recent studies have identified 2 distinct genetic variants along chromosome 17, including allele T of single nucleotide polymorphism rs4430796 on 17q12 and allele G of single nucleotide polymorphism rs1859962 on 17q24, that have been linked to prostate cancer risk. 19371897

2009

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Specifically, we sought to evaluate for effect modification between DM, a newly discovered prostate cancer susceptibility locus on chromosome 17q12 (single nucleotide polymorphism rs4430796) and prostate cancer features. 19627283

2009

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.740 GeneticVariation GWASCAT Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. 19767753

2009

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Three HNF1B SNPS, rs11649743, rs4430796, and rs7501939, were associated with decreased risk of prostate cancer and were also associated, with marginal statistical significance, with increased risk of diabetes. 19998368

2010

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.740 GeneticVariation BEFREE Three HNF1B SNPS, rs11649743, rs4430796, and rs7501939, were associated with decreased risk of prostate cancer and were also associated, with marginal statistical significance, with increased risk of diabetes. 19998368

2010

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE These associations remained significant after excluding HNF1B SNP rs4430796 (a known PCa risk factor) from the analysis. 20203524

2010

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The per-T2D-risk-allele odds ratios (95% confidence intervals) for rs4430796 were 0.79 (0.76, 0.83)] per G allele for prostate cancer (p<10(-15) for both); and 1.03 (0.99, 1.07) for all other cancers. 20526366

2010

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.740 GeneticVariation BEFREE Similarly for rs7501939 the per-T2D-risk-allele odds ratios (95% confidence intervals) were 0.80 (0.77, 0.83) per T allele for prostate cancer (p<10(-15) for both); and 1.00 (0.97, 1.04) for all other cancers. 20526366

2010

dbSNP: rs7501939
rs7501939
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.740 GeneticVariation GWASCAT Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. 20676098

2010

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes. 21499250

2011

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE After adjustments for age, the C allele of rs6983561 and the A allele of rs4430796 were significantly more frequent among the SPCa patients than among the controls. 21557267

2011

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Ten SNPs were significantly related to prostate cancer risk at a genome-wide significance level of P < 5 × 10(-8) with the most significant association with rs4430796 (P = 1.62 × 10(-24)). 21576123

2011

dbSNP: rs11649743
rs11649743
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.730 GeneticVariation BEFREE As expected, rs11649743 was related to prostate cancer risk (P = 3.54 × 10(-8)); however, the association within this second locus was stronger for rs4794758 (P = 4.95 × 10(-10)), which explained all of the risk observed with rs11649743 when both SNPs were included in the same model (P = 0.32 for rs11649743; P = 0.002 for rs4794758). 21576123

2011

dbSNP: rs4794758
rs4794758
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 GeneticVariation BEFREE As expected, rs11649743 was related to prostate cancer risk (P = 3.54 × 10(-8)); however, the association within this second locus was stronger for rs4794758 (P = 4.95 × 10(-10)), which explained all of the risk observed with rs11649743 when both SNPs were included in the same model (P = 0.32 for rs11649743; P = 0.002 for rs4794758). 21576123

2011

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Six markers associated with early-onset prostate cancer [rs2171492 (7q32), rs6983561 (8q24), rs10993994 (10q11), rs4430796 (17q12), rs1799950 (17q21), and rs266849 (19q13)] were genotyped. 22144497

2012

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Individuals with the rs4430796 TT genotype were at increased CaP risk in the Chinese via a recessive model (odds ratios (OR) = 1.56, 95% CI = 1.04-2.33). 22561070

2013

dbSNP: rs757210
rs757210
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 GeneticVariation BEFREE Ten T2D markers near 9 loci (NOTCH2, ADCY5, JAZF1, CDKN2A/B, TCF7L2, KCNQ1, MTNR1B, FTO, and HNF1B) were nominally associated with PCa (P < 0.05); the association for single nucleotide polymorphism rs757210 at the HNF1B locus was significant when multiple comparisons were accounted for (adjusted P = 0.001). 23193118

2012

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Genotype TG on 11q13 (rs7931342, T) could be related to an increased Gleason score, AG on HNF1B (rs4430796, A) could be associated with PSA increase, and TG on 17q24 (rs1859962, G) could be negatively associated with an increased BMI in Chinese men with PCa. 23464444

2012

dbSNP: rs4430796
rs4430796
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The polymorphism rs4430796 of the chromosome 17q12 appears to be a biomarker for cancer aggressiveness, increased PSA and tumor volume of PCa. 24627192

2014

dbSNP: rs2005705
rs2005705
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
G 0.700 GeneticVariation GWASCAT Genome-wide association scan for variants associated with early-onset prostate cancer. 24740154

2014